| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |